Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.


Butler J., McMullan C. J., Anstrom K. J., Barash I., Bonaca M. P., Borentain M., ...Daha Fazla

Lancet (London, England), cilt.406, sa.10510, ss.1341-1350, 2025 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 406 Sayı: 10510
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/s0140-6736(25)01665-4
  • Dergi Adı: Lancet (London, England)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Abstracts in Social Gerontology, Artic & Antarctic Regions, BIOSIS, CINAHL, EMBASE, MEDLINE, Psycinfo, Public Affairs Index, Nature Index
  • Sayfa Sayıları: ss.1341-1350
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

This paper has been written to mark 25 years of operational medium-range ensemble forecasting. The origins of the ECMWF Ensemble Prediction System are outlined, including the development of the precursor real-time Met Office monthly ensemble forecast system. In particular, the reasons for the development of singular vectors and stochastic physics - particular features of the ECMWF Ensemble Prediction System - are discussed. The author speculates about the development and use of ensemble prediction in the next 25 years.